Root Canal Obturation With a Ready-to-use Root Canal Sealer (PA1704) Versus BioRoot™ RCS: a Randomized Controlled Trial
OPTIFILL
Evaluation of the Efficacy Rate of Endodontic Treatment at 2 Years After Root Canal Filling With a Ready-to-use Root Canal Sealer PA1704 Versus BioRoot™ RCS: a Randomized Controlled Trial
3 other identifiers
interventional
160
2 countries
5
Brief Summary
The study design is a multicentric randomized controlled non-inferiority trial. 160 subjects (teeth) requiring a primary or a secondary root canal treatment will be enrolled in 2 groups (80 in each group). The aim of the study is to assess the efficacy rate and the safety 2 years after root canal obturation undertaken using a ready-to-use calcium silicate sealer (PA1704) compared to the control calcium silicate sealer BioRoot™ RCS. Procedures of root canal treatment will be conventional and standardized for all investigational centers. The canals will be cleaned, shaped and then obturated using a calcium silicate sealer (the ready to use sealer PA1704 or BioRoot™ RCS) with a single cone technique or cold lateral condensation of gutta-percha. Follow-up assessments will be conducted at 6, 12 and 24 months in both groups. The performance and safety of the sealer PA1704 will also be evaluated at 3.5 and 5 years after surgery. Retroalveolar radiographs will be taken at each study visit. The preoperative, postoperative and follow-up clinical and radiographic data will be analyzed.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Nov 2020
Longer than P75 for not_applicable
5 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 6, 2020
CompletedFirst Submitted
Initial submission to the registry
February 12, 2021
CompletedFirst Posted
Study publicly available on registry
February 17, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 29, 2023
CompletedResults Posted
Study results publicly available
October 10, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2026
ExpectedJune 26, 2025
June 1, 2025
2.8 years
February 12, 2021
April 15, 2024
June 18, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Efficacy Rate of Root Canal Obturation
Efficacy rate of root canal obturation using clinical and radiological criteria. A successfull treatment is defined in this study, based on some loose criteria, as: a functional tooth with no lesion on the radio, or a functional tooth with a size reduction of the lesion on the radio, or a functional tooth with a lesion size stabilisation.
24 months post-treatment
Secondary Outcomes (5)
Efficacy Rate of Root Canal Obturation
12 months post-treatment
Efficacy Rate of Root Canal Obturation
6 months post-treatment
Radiological Evaluation of the Canal Obturation
24-months post-treatment
Postoperative Pain
Before endodontic treatment*; before session#2 initiation**; T0 (after canal obturation); 12; 24; 48; & 72h; 7 days after endodontic treatment. *Evaluation on same day for 1-session treatment; up to 18 days before if 2 sessions needed. **On same day.
Use of Oral Pain Treatment
From Day 0 to Day 7
Study Arms (2)
ready-to-use root canal sealer: PA1704
EXPERIMENTALPA1704 is used in combination with gutta percha points for the permanent obturation of root canals.
root canal sealer: BioRoot™ RCS
OTHERBioRoot™ RCS is used in combination with gutta percha points for the permanent obturation of root canals.
Interventions
The participant will be treated with the ready-to-use root canal sealer (PA1704) in combination with gutta percha.
The participant will be treated with BioRoot™ RCS sealer in combination with gutta percha.
Eligibility Criteria
You may qualify if:
- Adult male or female (age ≥ 18 years)
- Patient requiring a primary or a secondary root canal obturation on a single or multi-rooted tooth,
- Patient geographically stable who can be followed by the same investigator site for 2 years,
- Informed consent signed,
- Patient with social protection
You may not qualify if:
- Patient with one or more documented contraindication to endodontic treatment,
- Contraindication to the use of calcium silicate root canal sealer, such as an immature tooth or a known hypersensitivity to one component of the sealer formula,
- Endodontic treatment on tooth with calcified root canal assessed radiographically,
- Endodontic treatment on tooth with suspected perforation,
- Patient with an uncontrolled systemic disease such as diabetes or thyroid disorders, or with an immunocompromised condition or who has undergone radiation therapy to the jaw.
- Patient suffering from uncontrolled active periodontitis, not supported
- Participation to another interventional clinical study at the same time,
- Vulnerable subjects referred to in articles L.1121-5 to 8 and L.1122-1-2 of the Public Health Code and article 66 of Regulation (EU) 2017/745 on medical devices are excluded from the investigation (such as known pregnancy or lactation, patients with legal protection).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Septodontlead
- Slb Pharmacollaborator
Study Sites (5)
Cliniques Universitaires Saint-Luc, Département de Médecine Dentaire et de Stomatologie
Brussels, 1200, Belgium
Centre de santé dentaire Flandre
Paris, 75019, France
Cabinet dentaire
Rennes, 35000, France
Cabinet dentaire Jeanne d'Arc
Rouen, 76000, France
Cabinet dentaire
Saint-Grégoire, 35760, France
Related Publications (1)
Simon S, Beauquis J, Colombel H, Dorn A, Marchi V, Robert S, Souleau G, Ravalec N, Huguet-Jaime F, Chazaud K, Serandour AL, Ournid N, Leprince JG. Clinical efficacy of root canal treatment at 2 years using a new ready-to-use injectable calcium silicate-based sealer: A multicentric randomised controlled trial. Int Endod J. 2025 Sep;58(9):1420-1432. doi: 10.1111/iej.14265. Epub 2025 Jun 10.
PMID: 40491343RESULT
Results Point of Contact
- Title
- Dr. Farid BENABDALLAH
- Organization
- SEPTODONT
Study Officials
- PRINCIPAL INVESTIGATOR
Stéphane Simon, Pr, DDS
Cabinet dentaire Jeanne d'Arc - ROUEN (76000) - France
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Blinding will be done to the assessors who analyzed radiographs to reduce bias to healing assessment.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 12, 2021
First Posted
February 17, 2021
Study Start
November 6, 2020
Primary Completion
August 29, 2023
Study Completion (Estimated)
July 1, 2026
Last Updated
June 26, 2025
Results First Posted
October 10, 2024
Record last verified: 2025-06
Data Sharing
- IPD Sharing
- Will not share